| 000 | 01831 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250514164538.0 | ||
| 264 | 0 | _c20040220 | |
| 008 | 200402s 0 0 eng d | ||
| 022 | _a0066-4804 | ||
| 024 | 7 |
_a10.1128/AAC.48.1.124-129.2004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHazra, Rohan | |
| 245 | 0 | 0 |
_aSingle-dose and steady-state pharmacokinetics of tenofovir disoproxil fumarate in human immunodeficiency virus-infected children. _h[electronic resource] |
| 260 |
_bAntimicrobial agents and chemotherapy _cJan 2004 |
||
| 300 |
_a124-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article | ||
| 650 | 0 | 4 |
_aAdenine _xadverse effects |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xadverse effects |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Infections _xmetabolism |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aOrganophosphonates |
| 650 | 0 | 4 |
_aOrganophosphorus Compounds _xadverse effects |
| 650 | 0 | 4 | _aTenofovir |
| 700 | 1 | _aBalis, Frank M | |
| 700 | 1 | _aTullio, Antonella N | |
| 700 | 1 | _aDeCarlo, Ellen | |
| 700 | 1 | _aWorrell, Carol J | |
| 700 | 1 | _aSteinberg, Seth M | |
| 700 | 1 | _aFlaherty, John F | |
| 700 | 1 | _aYale, Kitty | |
| 700 | 1 | _aPoblenz, Marianne | |
| 700 | 1 | _aKearney, Brian P | |
| 700 | 1 | _aZhong, Lijie | |
| 700 | 1 | _aCoakley, Dion F | |
| 700 | 1 | _aBlanche, Stephane | |
| 700 | 1 | _aBresson, Jean Louis | |
| 700 | 1 | _aZuckerman, Judith A | |
| 700 | 1 | _aZeichner, Steven L | |
| 773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 48 _gno. 1 _gp. 124-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.48.1.124-129.2004 _zAvailable from publisher's website |
| 999 |
_c14424402 _d14424402 |
||